News

Presentation and Poster at Antibody Engineering & Therapeutics

Daniel Bedinger, PhD, our West Coast Senior Field Applications Scientist spoke about accelerating your antibody discovery with high throughput Array SPR.

Read More

Carterra Continues Successful Antibody Discovery Seminars with new US East Coast Event

Industry leaders gather in Cambridge, MA on December 5, 2018 to discuss innovative methods for accelerating antibody discovery.

Read More

Presentation and Poster at PEGS Europe

Phil Leighton, PhD, Director of Molecular Biology at Ligand Pharmaceuticals spoke about epitope mapping of human antibodies from transgenic chickens.

Read More

Antibody Discovery Industry Leaders Speak at Carterra’s September 18, 2018 Seminar

Array SPR has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step.

Read More

Expert View Article in Drug Target Review

Explore the full kinetic and epitope diversity of large antibody libraries with high throughput Array SPR (Surface Plasmon Resonance).

Read More

DDW Article on Analytical Biophysical Tools To Accelerate Discovery of Therapeutic Antibodies

The demand for higher throughput analytics is needed to support the paradigm shift that is emerging in the industry towards a deeper appreciation of the epitope diversity offered within an antibody library by applying higher resolution and higher throughput methods for epitope characterization at the earliest stages of research.

Read More

Carterra CEO, Josh Eckman, Recognized as a Rising Star by the David Eccles School of Business

Carterra^® Inc., a provider of innovative drug discovery technologies, announced that its CEO, Josh Eckman, has been honored as a Rising Star by The University of Utah David Eccles School of Business during its 2018 Hall of Fame induction ceremony.

Read More

LakePharma Expands Service Capability with Purchase of Carterra High Throughput Antibody Characterization LSA™ Instrumentation

First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business

Read More

Institute for Protein Innovation Buys Carterra Next-Generation Antibody Characterization LSA™ Instrumentation

First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery

Read More

Carterra Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization

First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions.

Read More